Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets
Journal of Pharmacy and Pharmacology · 16.01.2026 · 78 (1)
DOI: 10.1093/jpp/rgaf093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 30.09.2025. Verfasst von Enas Bani-Ahmad und 2 weiteren Autor:innen. Beteiligte Einrichtung: Curtin Medical School, Curtin University, Kent St, Bentley 6102, Australia. Hauptthemen laut MEDLINE: Signal Transduction, Head and Neck Neoplasms, Carcinoma, Squamous Cell, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
This review examines the signalling pathways involved in head and neck cancer cell survival and apoptosis.
Methods
Articles were sourced from Scopus using the following keywords: oral cavity cancer, head and neck squamous cell carcinoma, signalling pathways, target therapy. No publication date limits were set, and the language of publication was restricted to English. Key findings Head and neck cancers are the sixth most common cancer worldwide (head and neck squamous cell carcinoma [HNSCC]). The most common subtype is squamous cell carcinoma (SCC), with oral and oropharyngeal squamous cell carcinoma (OSCC and OPSCC, respectively) being significant subcategories. Multiple signalling pathways play a critical role in oncogenesis and the development of various head and neck malignancies. Theoretically, targeting inhibitors for these pathways could potentially halt tumour growth and restore affected cells. This review highlights key oncogenic cascades, including epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT/mTOR, mitogen-activated protein kinase/extracellular signal-regulated kinase, Wnt/β-catenin, NOTCH, the p53 gene, and vascular endothelial growth factor, which contribute to tumour progression, invasion, and therapeutic resistance. A comprehensive understanding of these molecular mechanisms is essential to inform targeted therapies and develop personalized treatment strategies for HNSCC.
Conclusions
Researchers have studied several signalling pathways in HNSCC due to their known ability to influence apoptosis, survival, angiogenesis, and other biological processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Curtin Medical School, Curtin University, Kent St, Bentley 6102, Australia.
- Curtin Medical Research Institute, Curtin University, Kent St, Bentley 6102, Australia.
- Jordan University of Science and Technology, Irbid 3030, Jordan.
- Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands 6009, Australia.
- Silpakorn University, Nakhon Pathom 73000, Thailand.
ORCID-Profile: Crispin R Dass
Zitieren
APA
Bani-Ahmad, E., Dass, J., & Dass, C. R. (2026). Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets. Journal of Pharmacy and Pharmacology, 78(1). https://doi.org/10.1093/jpp/rgaf093
Vancouver
Bani-Ahmad E, Dass J, Dass CR. Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets. Journal of Pharmacy and Pharmacology. 2026;78(1). doi:10.1093/jpp/rgaf093
BibTeX
@article{BaniAhmad2026,
author = {Bani-Ahmad, Enas and Dass, Joshua and Dass, Crispin R},
title = {Key signalling pathways in head and neck squamous cell carcinoma: mechanisms and therapeutic targets},
journal = {Journal of Pharmacy and Pharmacology},
year = {2026},
volume = {78},
number = {1},
doi = {10.1093/jpp/rgaf093}
}
EUVIMED